Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Target Detachable Coils

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall Target Detachable Coils see related information
Date Initiated by Firm June 06, 2016
Date Posted July 11, 2016
Recall Status1 Terminated 3 on March 03, 2017
Recall Number Z-2164-2016
Recall Event ID 74425
510(K)Number K113412  K153658  
Product Classification Device, neurovascular embolization - Product Code HCG
Product Target Detachable Coils:
TARGET 360 NANO 1.5 MM X 4 CM
MODEL Number:M0035421540

Neurology: Target Detachable Coils are intended to endovascularly obstruct or occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels.
Code Information MODEL Number: M0035421540  Lot Number/Expiration Date: 18808912 31-Jan-19 18741434 31-Dec-18 18714072 30-Nov-18 18677229 30-Nov-18 18625483 31-Oct-18 18625541 31-Oct-18 18642784 31-Oct-18 18633921 31-Oct-18 18598299 30-Sep-18 18590470 30-Sep-18 18542363 31-Aug-18 18420011 31-May-18 18419897 31-May-18 18833256 28-Feb-19 18808618 31-Jan-19 18787244 31-Jan-19 18677171 30-Nov-18 18524564 31-Jul-18 18524622 31-Jul-18 18832645 31-Jan-19 18768683 31-Dec-18 18756119 31-Dec-18 18725503 30-Nov-18 18666721 31-Oct-18 18642842 31-Oct-18 18642668 31-Oct-18 18598183 30-Sep-18 18590528 30-Sep-18 18578953 30-Sep-18 18406806 31-May-18 18809794 31-Jan-19 18787859 31-Jan-19 18755053 31-Dec-18 18741144 31-Dec-18 18701144 30-Nov-18 18590586 30-Sep-18 18579069 30-Sep-18 18549270 31-Aug-18 18420182 31-May-18 18420239 31-May-18 18809206 31-Jan-19 18817972 28-Feb-19 18701318 30-Nov-18 18677113 30-Nov-18 18488340 31-Jul-18 18598125 30-Sep-18 18542305 31-Aug-18 18787449 31-Jan-19 18714246 30-Nov-18 18625599 31-Oct-18 18634037 31-Oct-18 18598241 30-Sep-18 18559192 31-Aug-18 18832034 31-Jan-19 18817309 28-Feb-19 18787654 31-Jan-19 18768041 31-Dec-18 18701260 30-Nov-18 18809500 31-Jan-19 18701202 30-Nov-18 18677287 30-Nov-18 18642726 31-Oct-18 18590412 30-Sep-18 18559250 31-Aug-18 19080127 31-May-19 19010580 30-Apr-19 18931017 31-Mar-19 18885811 28-Feb-19 18846227 28-Feb-19 19026877 30-Apr-19 19025829 30-Apr-19 19043083 31-May-19 18974705 30-Apr-19 18957691 31-Mar-19 18911592 31-Mar-19 18845848 28-Feb-19 19049933 31-May-19 18998580 30-Apr-19 18853712 28-Feb-19 18887225 28-Feb-19 19080305 31-May-19 19026353 30-Apr-19 18998638 30-Apr-19 18975142 30-Apr-19 18956531 31-Mar-19 19079949 31-May-19 18964774 31-Mar-19 19042039 30-Apr-19 19010180 30-Apr-19 18963382 31-Mar-19 18912801 31-Mar-19 18911995 31-Mar-19 18846606 28-Feb-19 18963846 31-Mar-19 18930672 31-Mar-19 18899164 28-Feb-19 18912398 31-Mar-19 18974268 30-Apr-19 18987031 30-Apr-19 19050975 31-May-19 19048891 31-May-19 19042561 31-May-19 19041517 30-Apr-19 18964310 31-Mar-19 18975579 30-Apr-19 18957111 31-Mar-19 18940339 31-Mar-19 18938917 31-Mar-19 18929982 31-Mar-19 18845469 28-Feb-19. 
Recalling Firm/
Manufacturer		 Stryker Neurovascular
47900 Bayside Pkwy
Fremont CA 94538-6515
For Additional Information Contact Geraldin Ahern
510-413-2593
Manufacturer Reason
for Recall		 Stryker Neurovascular has become aware that some units of Target Nano product do not have the intended stretch resistance. The sutures inside the coil that provide stretch resistance may have been damaged during manufacturing which can lead to an increased occurrence of coil stretching.
FDA Determined
Cause 2		 Process change control
Action Stryker Neurovascular sent an Urgent Medical Device Voluntary Recall letter dated June 3, 2016, to all affected customers via FED Ex. Letter includes recall letter, list of impacted lot numbers, customer acknowledgement form and frequently asked questions. Customers were instructed to immediately check their inventory. segregate the effected inventory in a secure location for return to Stryker, circulate the Field Safety Notice internally to all interested/affected parties. Inform Stryker if any of the subject devices have been distributed to other organizations. Customers were also instructed to complete the attached customer response form and return the completed form to their nominated Stryker Representative.
Quantity in Commerce 45,302 (8,188 in the U.S.) - total, all model numbers
Distribution Worldwide Distribution - US (nationwide) and Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Canary Islands, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Italia, Japan,Latvia, Lebanon, Libyan Arab Jamahiriya, Lithuania, Luxembourg, Mexico,Netherlands, Norway, Peru, Philippines, Poland, Portugal, Russia, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates, United Kingdom, United States, Uruguay, and Vietnam.
Total Product Life Cycle TPLC Device Report
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
510(K) Database 510(K)s with Product Code = HCG and Original Applicant = STRYKER NEUROVASCULAR
-
-